反応 #92267

ord-0e56418c1def440cadc6f221c7aece8c

反応方程式

CCN(C(C)C)C(C)C
DIEA
Nc1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3Cl)nc12
(R)-5-(2-(2-chloro-5-fluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine
O=C(n1ccnc1)n1ccnc1
CDI
Cl.OC1CNC1
azetidin-3-ol hydrochloride
O=C(Nc1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3Cl)nc12)N1CC(O)C1
final product
収率 85.1%
O=C(Nc1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3Cl)nc12)N1CC(O)C1
(R)—N-(5-(2-(2-chloro-5-fluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxyazetidine-1-carboxamide
収率 85.1%

溶媒

反応条件

詳細条件
See reaction.notes.procedure_details.

後処理

  1. 1
    workup.STIRRINGThe reaction was stirred for 5 minutes before it
  2. 2
    濃縮was concentrated
  3. 3
    その他directly purified by reverse-phase column chromatography
  4. 4
    洗浄eluting with 5 to 50% acetonitrile/water

実験手順

To a DCM (0.8 mL) solution of (R)-5-(2-(2-chloro-5-fluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine (30 mg, 0.090 mmol) was added CDI (29 mg, 0.18 mmol) at ambient temperature in one portion. After stirring two hours, azetidin-3-ol hydrochloride (20 mg, 0.18 mmol) was added in one portion, followed by addition of DIEA (0.047 mL, 0.27 mmol). The reaction was stirred for 5 minutes before it was concentrated and directly purified by reverse-phase column chromatography, eluting with 5 to 50% acetonitrile/water to yield the final product as a yellowish foamy powder (33 mg, 85% yield). MS (apci) m/z=431.1 (M+H).

出典

DOI: 10.6084/m9.figshare.5104873.v1特許: US09447104B2uspto-grants-2016_09